[Interstitial pneumopathies in children treated for malignant diseases]

Area of Science:

• Pediatric Oncology
• Pulmonology
• Infectious Diseases

Background:

• Severe interstitial pneumonitis is a significant complication in pediatric cancer patients undergoing intensive chemotherapy.
• This condition was observed in 21 cases in Paris in 1974, affecting children with solid tumors or leukemias.

Purpose of the Study:

• To review the incidence and clinical presentation of severe interstitial pneumonitis in pediatric oncology patients.
• To highlight the diagnostic challenges, including the severe prognosis of measles and frequent Pneumocystis carinii infections.
• To discuss diagnostic procedures, immune status, and treatment strategies for pneumonitis in immunosuppressed children.

Main Methods:

• Retrospective case review of 21 children with severe interstitial pneumonitis.
• Analysis of clinical symptoms, radiological findings, and diagnostic procedures including surgical pulmonary biopsy.
• Evaluation of immune status, focusing on cellular and humoral immunity.

Main Results:

• Twelve out of 21 patients with severe interstitial pneumonitis died.
• Measles infection presented a particularly poor prognosis in this patient group.
• Impaired cellular immunity (low lymphocyte count) was noted, while humoral immunity remained unchanged.
• Pneumocystis carinii infection was frequently observed.

Conclusions:

• Diagnosis and treatment of pneumonitis in immunosuppressed pediatric patients are challenging.
• Prevention strategies, including careful chemotherapy protocol management, are essential.
• Prompt recognition and management of infections like measles and Pneumocystis carinii are critical for improving outcomes.